Development of a dual luciferase activity and fluorescamine protein assay adapted to a 384 micro-well plate format: Reducing variability in human luciferase transactivation cell lines aimed at endocrine active substances. [electronic resource]
Producer: 20180918Description: 18-25 p. digitalISSN:- 1879-3177
- Antineoplastic Agents -- pharmacology
- Biological Assay
- Breast Neoplasms -- chemically induced
- Cell Line, Tumor
- Cell-Free System -- drug effects
- Endocrine Disruptors -- toxicity
- Female
- Fluorescamine -- analysis
- Fluorescent Dyes -- analysis
- Gene Expression Regulation, Neoplastic -- drug effects
- Genes, Reporter -- drug effects
- High-Throughput Screening Assays
- Hormone Antagonists -- pharmacology
- Humans
- Kinetics
- Limit of Detection
- Luciferases -- genetics
- Recombinant Proteins -- metabolism
- Reproducibility of Results
- Transcriptional Activation -- drug effects
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.